[HTML] springer.com

[HTML][HTML] S1-RECENT ADVANCES IN PLASMA BIOMARKERS TO IMPROVE PRECLINICAL AND PRODROMAL AD TRIALS.

K Blennow, J Dage, R Bateman, O Hansson - 2021 - Springer
Background: Recent advances in the development of novel Alzheimer's disease (AD)
measures of amyloid, tau, and neurodegeneration in blood have enabled the ability to …
被引用次数：1 相关文章
[HTML] nih.gov

[HTML][HTML] S1-RECENT ADVANCES IN PLASMA BIOMARKERS TO IMPROVE PRECLINICAL AND PRODROMAL AD TRIALS.

K Blennow, J Dage, R Bateman, O Hansson - 2021 - ncbi.nlm.nih.gov
Background: Recent advances in the development of novel Alzheimer's disease (AD)
measures of amyloid, tau, and neurodegeneration in blood have enabled the ability to …